Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Diabetes Mellitus, Type 2.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
6.331
Diabetes Mellitus, Type 2
  1. Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes. Curr Opin Nephrol Hypertens. 2022 01 01; 31(1):26-35.
    View in: PubMed
    Score: 0.589
  2. Biologically plausible trends suggesting that a low-protein diet may enhance the effect of flozination caused by the sodium-glucose cotransporter-2 inhibitor dapagliflozin on albuminuria. Diabetes Obes Metab. 2021 12; 23(12):2825-2826.
    View in: PubMed
    Score: 0.576
  3. Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):705-716.
    View in: PubMed
    Score: 0.562
  4. Metformin in chronic kidney disease: a strong dose of caution. Kidney Int. 2020 11; 98(5):1101-1105.
    View in: PubMed
    Score: 0.544
  5. Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis. Nat Rev Nephrol. 2017 09; 13(9):521-522.
    View in: PubMed
    Score: 0.433
  6. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data. Nephron. 2017; 135(2):147-153.
    View in: PubMed
    Score: 0.411
  7. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety! Diabetes Care. 2016 Jul; 39(7):1281-6.
    View in: PubMed
    Score: 0.403
  8. Restricting Metformin in CKD: Continued Caution Warranted. Am J Kidney Dis. 2015 Dec; 66(6):1101-2.
    View in: PubMed
    Score: 0.387
  9. Metformin in chronic kidney disease: more harm than help? Lancet Diabetes Endocrinol. 2015 Aug; 3(8):579-81.
    View in: PubMed
    Score: 0.375
  10. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep. 2012 Aug; 12(4):432-9.
    View in: PubMed
    Score: 0.307
  11. Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 01 01; 31(1):72-81.
    View in: PubMed
    Score: 0.147
  12. Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis. Semin Dial. 2021 09; 34(5):388-393.
    View in: PubMed
    Score: 0.143
  13. Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovasc Diabetol. 2021 06 22; 20(1):125.
    View in: PubMed
    Score: 0.142
  14. Diabetes and the Gut Microbiome. Semin Nephrol. 2021 03; 41(2):104-113.
    View in: PubMed
    Score: 0.139
  15. Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study. Cardiovasc Diabetol. 2021 01 07; 20(1):13.
    View in: PubMed
    Score: 0.138
  16. Plant-Based Diets for Kidney Disease: A?Guide for Clinicians. Am J Kidney Dis. 2021 02; 77(2):287-296.
    View in: PubMed
    Score: 0.136
  17. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2020 04 28; 323(16):1565-1573.
    View in: PubMed
    Score: 0.131
  18. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
    View in: PubMed
    Score: 0.125
  19. Smoking and Other Risk Factors in Type 2 Diabetes. N Engl J Med. 2018 Dec 27; 379(26):2572-2573.
    View in: PubMed
    Score: 0.120
  20. Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. J Diabetes Complications. 2018 Dec; 32(12):1113-1117.
    View in: PubMed
    Score: 0.117
  21. Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant. 1997 Sep; 12(9):1988-90.
    View in: PubMed
    Score: 0.109
  22. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33.
    View in: PubMed
    Score: 0.089
  23. Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion. N Engl J Med. 2013 Jul 25; 369(4):374-82.
    View in: PubMed
    Score: 0.082
  24. Erythropoietin in kidney disease and type 2 diabetes. N Engl J Med. 2011 01 27; 364(4):384-5; author reply 385-6.
    View in: PubMed
    Score: 0.069
  25. A Mini Review of Plant-Based Diets in Hemodialysis. Blood Purif. 2021; 50(4-5):672-677.
    View in: PubMed
    Score: 0.035
  26. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.